{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:58:00Z","timestamp":1781236680077,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","arthroplastyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.arth.2023.11.037","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T13:42:45Z","timestamp":1701697365000},"page":"1500-1504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risks Following Total Knee Arthroplasty in Patients Who Have Antiphospholipid Syndrome"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9225-2828","authenticated-orcid":false,"given":"Zhichang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2825-7361","authenticated-orcid":false,"given":"Jialun","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Duensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzaifah","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4285-4488","authenticated-orcid":false,"given":"Quanjun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2023.11.037_bib1","first-page":"668","article-title":"Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease","volume":"27","author":"Palomo","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arth.2023.11.037_bib2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.arth.2023.11.037_bib3","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/art.41401","article-title":"Antiphospholipid syndrome is still a rare disease-estimated prevalence in the piedmont and aosta valley regions of northwest italy: comment on the article by duarte-garc\u00eda et\u00a0al","volume":"72","author":"Radin","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.arth.2023.11.037_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.715878","article-title":"Use of direct oral anticoagulants in patients with antiphospholipid syndrome: a systematic review and comparison of the International guidelines","volume":"8","author":"Pastori","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.arth.2023.11.037_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arth.2023.11.037_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.arth.2023.11.037_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.843718","article-title":"Patterns of recurrent thrombosis in primary antiphospholipid syndrome-multicenter, real-life long-term follow-up","volume":"13","author":"Niznik","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.arth.2023.11.037_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.thromres.2004.08.003","article-title":"Primary, secondary, catastrophic antiphospholipid syndrome: is there a difference?","volume":"114","author":"Harris","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.arth.2023.11.037_bib9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arth.2023.11.037_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.arth.2023.11.037_bib11","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.11.037_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0961203316636467","article-title":"Musculoskeletal manifestations of the antiphospholipid syndrome","volume":"25","author":"Noureldine","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.arth.2023.11.037_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2474-11-86","article-title":"Clinical predictors of elective total joint replacement in persons with end-stage knee osteoarthritis","volume":"11","author":"Zeni","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.arth.2023.11.037_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12891-015-0470-0","article-title":"Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years","volume":"16","author":"Zhang","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.arth.2023.11.037_bib15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1302\/0301-620X.84B4.0840566","article-title":"Incidence and natural history of deep-vein thrombosis after total knee arthroplasty","volume":"84-B","author":"Kim","year":"2002","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2023.11.037_bib16","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00402-022-04475-5","article-title":"How does systemic lupus erythematosus impact the peri-operative complication rates in primary hip arthroplasty? A national inpatient sample-based study","volume":"143","author":"Viswanathan","year":"2022","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.arth.2023.11.037_bib17","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.arth.2022.05.043","article-title":"2022 American college of rheumatology\/American association of hip and knee surgeons guideline for the perioperative management of Antirheumatic Medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"37","author":"Goodman","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.11.037_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13018-022-03075-8","article-title":"A\u00a0systematic review and meta-analysis comparing complications following total hip arthroplasty for systemic lupus erythematosus versus for non-systemic lupus erythematosus","volume":"17","author":"Huang","year":"2022","journal-title":"J\u00a0Orthop Surg Res"},{"key":"10.1016\/j.arth.2023.11.037_bib19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00264-018-3871-5","article-title":"Is osteonecrosis due to systemic lupus erythematosus associated with increased risk of complications following total hip arthroplasty?","volume":"42","author":"Chen","year":"2018","journal-title":"Int Orthop"},{"key":"10.1016\/j.arth.2023.11.037_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.rhu.0000135559.95451.b2","article-title":"Avascular necrosis of bone associated with primary antiphospholipid syndrome: case report and literature review","volume":"10","author":"Zonana-Nacach","year":"2004","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.arth.2023.11.037_bib21","first-page":"15","article-title":"Secondary erosive arthritis in a young lady \u2013 a rare manifestation of primary antiphospholipid antibody syndrome","volume":"11","author":"Muthu","year":"2021","journal-title":"J\u00a0Orthop Case Rep"},{"key":"10.1016\/j.arth.2023.11.037_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/142615","article-title":"Anti-phospholipid antibodies in patients undergoing total joint replacement surgery","volume":"2012","author":"Simpson","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.arth.2023.11.037_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.arth.2023.11.037_bib24","article-title":"Efficacy and safety of direct oral anticoagulants in patients with antiphospholipid syndrome: a systematic review and meta-analysis","volume":"14","author":"Gullapalli","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.arth.2023.11.037_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2021.12.001","article-title":"Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study","volume":"209","author":"Bucci","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.arth.2023.11.037_bib26","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/ijms24043169","article-title":"A\u00a0comprehensive review of risk factors for venous thromboembolism: from epidemiology to Pathophysiology","volume":"24","author":"Pastori","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arth.2023.11.037_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arth.2023.11.037_bib28","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.arth.2023.11.037_bib29","first-page":"160","article-title":"New approaches for managing antiphospholipid syndrome","volume":"5","author":"Erkan","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.arth.2023.11.037_bib30","first-page":"6984","article-title":"Anticoagulant therapy in patients with antiphospholipid syndrome","volume":"11","author":"Capecchi","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.arth.2023.11.037_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11926-014-0426-7","article-title":"Perioperative management of antiphospholipid antibody-positive patients","volume":"16","author":"Saunders","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.arth.2023.11.037_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2106\/JBJS.22.00607","article-title":"Commercial claims data sources: PearlDiver and individual payer databases","volume":"104","author":"Bolognesi","year":"2022","journal-title":"J\u00a0Bone Joint Surg Am"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540323011907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540323011907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:41:26Z","timestamp":1725450086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540323011907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0883540323011907"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2023.11.037","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks Following Total Knee Arthroplasty in Patients Who Have Antiphospholipid Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2023.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}